4th EPHA Universal Access and Affordable Medicines Forum
Time for a New Deal: Challenging the status quo on medicines policy #newdeal4meds
14 November
09:30-17:00
18 speakers
Over 5 sessions
Scotland House
Brussels
The annual one-day multi-stakeholder Forum on access to medicines in Europe organised by the European Public Health Alliance (EPHA).
The 4th EPHA Universal Access and Affordable Medicines Forum provided stimulating and lively discussions on the hottest topics in the access to medicines debate, including: pharma and medicines policies, affordability, R&D (research and development), innovation, transparency in pharmaceuticals, shortages, patient safety, health technology assessment (HTA).
speakers
participants
Twitter reach
Re-live the event
Programme
09:30 - 09:45 Welcome and introduction
- Fiona Godfrey, Secretary General, European Public Health Alliance (EPHA) @fjgodfrey @EPHA_EU
09:45 - 11:10 EU plans around cancer: Hype VS substance
- Denis Lacombe, Director-General, European Organisation for Research and Treatment of Cancer (EORTC) @EORTC
- Kathi Apostolidis, President, European Cancer Patient Coalition (ECPC) @cancereu @kgapo
- Carin Uyl-de Groot, Professor, Health Technology Assessment, Director of the Institute for Medical Technology Assessment (iMTA), School of Health Policy & Management, Erasmus University Rotterdam @ESHPM_EUR
- Ward Rommel, Researcher, Kom op tegen Kanker, Access to Medicines Task-Force,
European Cancer Leagues (ECL) @CancerLeagues @KOTKanker @WardRommel - Chantal Bélorgey, Head of the Health Technology Assessment (HTA) and Public Health division, French Health Authority (Haute Autorité de Santé – HAS) @HAS_sante
11:30 - 12:00 Access to medicines – high and unsustainable price levels: Keynote & brief exchange with Bjørn-Inge Larsen
- Bjørn-Inge Larsen, Secretary-General, Ministry of Health and Care Services, Norway
- Yannis Natsis, Policy Manager for Universal Access and Affordable Medicines, European Public Health Alliance (EPHA), Member Of The Management Board at European Medicines Agency (EMA) @ynatsis @EPHA_EU
13:00-14:25 An old new problem: Solutions to the medicines shortages in Europe
- Vlad Mixich, Coordinator, Romanian Health Observatory – Board member, EPHA @mixich
- Charlotte Roffiaen, EU advocacy advisor, France Assos Santé (FAS) @Fr_Assos_Sante @EU4Ublog
- Aida Batista, Vice-President, European Association of Hospital Pharmacists (EAHP) @EAHPtweet @AidaBatista
- Kasper Ernest, Secretary-General, European Association of Euro-Pharmaceutical Companies (EAEPC) @EAEPC_Brussels @KasperErnest
14:45-16:15 Pharmaceuticals, a secretive business: How to shed light into the black box?
- Ellen t’ Hoen LLM, PhD, Medicines Law & Policy @MedsLawPolicy @ellenthoen
- Audun Hågå, Head, Norwegian Medicines Agency
- Marcel van Raaij, Director of Pharmaceutical Affairs and Medical Technology, Ministry of Health, Welfare, and Sports, The Netherlands @MarcelvanRaaij
- Fergal O’ Regan, Head of Enquiries, European Ombudsman @EUombudsman
- Alexander Roediger, Executive Director Oncology Policy, Europe, Middle East, Africa and Canada (EMEAC), MSD International @MSDInvents
16:15-16:30 Closing remarks
16:30-17:30 Networking reception
Event Gallery
In the Press
Speakers
Aida Batista
Vice-President, European Association of Hospital Pharmacists (EAHP)
Charlotte Roffiaen
EU advocacy advisor, France Assos Santé (FAS)
Rohit Malpani
Board member, UNITAID
Ward Rommel
Access to Medicines Task-Force, European Cancer Leagues (ECL)
Fergal O' Reagan
European Ombudsman
Audun Hågå
Head, Norwegian Medicines Agency
Alexander Roediger
MSD International
Fiona Godfrey
European Public Health Alliance (EPHA)
Kathi Apostolidis
President, European Cancer Patient Coalition (ECPC)
Marcel van Raaij
Director of Pharmaceutical Affairs and Medical Technology, Ministry of Health, Welfare, and Sports, The Netherlands
Bjørn-Inge Larsen
Secretary-General, Ministry of Health and Care Services, Norway
Chantal Bélorgey
Head of the Health Technology Assessment (HTA) and Public Health division, French Health Authority (Haute Autorité de Santé - HAS)
(tbc)
Ellen t’ Hoen LLM, PhD
Medicines Law & Policy
Vlad Mixich
Coordinator, Romanian Health Observatory – Board member, EPHA
Carin Uyl-de Groot
Professor, Health Technology Assessment, Director of the Institute for Medical Technology Assessment (iMTA), School of Health Policy & Management, Erasmus University Rotterdam
Denis Lacombe
Director-General, European Organisation for Research and Treatment of Cancer (EORTC)
Yannis Natsis
European Public Health Alliance (EPHA)
Kasper Ernest
Secretary-General, European Association of Euro-Pharmaceutical Companies (EAEPC)
The debate on social media
No more business as usual when it comes to #accesstomedicines. Our societies have been prioritising economic interests over human interests. Fiona Godfrey @EPHA_EU calls for it to stop. #newdeal4meds #affordability #drugshortages #accesstocare pic.twitter.com/k0EiTu3Nw1
— Anne-Pierre Pickaert (@Care4Access) November 14, 2019
Head of Norwegian Medicines Agency says that the only way forward for governments is to work together and share information. “As long as, we continue to accept #confidentiality, #pharma will have the upper hand” he says at #newdeal4meds #accesstomedicines pic.twitter.com/o5n9IWyGGs
— Yannis Natsis (@YNatsis) November 14, 2019
"Low evidence, high price. The challenge is to find the right balance between timely approval, uncertainty and budget constrains" says Chantal Belorgey of @HAS_sante #newdeal4meds
— Viviana Galli (@Vivivovi) November 14, 2019
"Our work has led to several changes in the #transparency and accountability of @EMA_News, which increases trust in the agency, and has real benefits for patients." - @f_oregan
— European Ombudsman (@EUombudsman) November 14, 2019
✔️ https://t.co/NZ6uOHXdDb#newdeal4meds
"We are in talks with Denmark and Iceland to start negotiating together. We will learn all we can from #Beneluxa." says Dr Bjørn-Inge Larsen @helse_og_omsorg #newdeal4meds pic.twitter.com/2GIo9pEqWA
— EPHA (@EPHA_EU) November 14, 2019
If you want better price negotiations, show us the data, show us the costs. Audun Haga, head of Norwegian Medicines Agency, about #transparency #pharmaceutical #newdeal4meds @EPHA_EU
— Vlad Mixich (@mixich) November 14, 2019
Past EPHA Universal Access and Affordable Medicines Forums
EPHA 2018 Universal Access and Affordable Medicines Forum
20 November 2018
2017 EPHA Universal Access & Affordable Medicines Forum
21 November 2017
2016 EPHA Universal Access and Affordable Medicines Forum
29 November 2016
Contact
Policy
Yannis Natsis
Policy Manager Universal Access and Affordable Medicines
yannis@epha.org
+32 2 233 3886
Press
Giulia Vettore
Communications Manager
giulia@epha.org
+32 2 233 3884
Logistics
Selena Goksel
Events Coordinator
selena@epha.org
+32 2 233 3875
